Approvals/TGA/EBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen)

Approved

STANDARD

EBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen)

Eli Lilly Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 242cbbb68f809c58
Product Name: EBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen)
Artg Id: 406290
Artg Name: EBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen)
Sponsor: Eli Lilly Australia Pty Ltd
Company Detail Path: /organization/eli-lilly-australia-pty-ltd
Artg Date: 2024-05-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/d692e1109071f9a2b47f03f5b8166a56.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/c89dec9fa71ee61876b9dfe47068f588.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

242cbbb68f809c58

Type

Standard